Global Gene Therapy for Inherited Genetic Disorders Market Insights, Forecast to 2029

Publisher Name :
Date: 01-Jun-2023
No. of pages: 97
Inquire Before Buying

In the medicine field gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.A genetic disorder is a genetic problem caused by one or more abnormalities formed in the genome.

Market Analysis and Insights: Global Gene Therapy for Inherited Genetic Disorders Market

The global Gene Therapy for Inherited Genetic Disorders market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Gene therapy has the potential to cure inherited diseases that cannot be cured using conventional drugs. It is being increasingly adopted in clinical trials because of its high efficacy and safety towards the treatment of inherited genetic disorders.

Report Includes

This report presents an overview of global market for Gene Therapy for Inherited Genetic Disorders market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Gene Therapy for Inherited Genetic Disorders, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Gene Therapy for Inherited Genetic Disorders, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gene Therapy for Inherited Genetic Disorders revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Gene Therapy for Inherited Genetic Disorders market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Gene Therapy for Inherited Genetic Disorders revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including BioMarin Pharmaceutical Inc., bluebird bio Inc., Novartis AG, Orchard Therapeutics Plc and Spark Therapeutics Inc., etc.

By Company

- BioMarin Pharmaceutical Inc.

- bluebird bio Inc.

- Novartis AG

- Orchard Therapeutics Plc

- Spark Therapeutics Inc.

Segment by Type

- Eye Disorders

- Hematological Disorders

- Central Nervous System Disorders

- Muscular Disorders

- Others

Segment by Application

- Hospital

- Clinic

- Research Institute

- Others

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East, Africa, and Latin America

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Gene Therapy for Inherited Genetic Disorders in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gene Therapy for Inherited Genetic Disorders companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by type, by application and by country, revenue for each segment.

Chapter 7: Europe by type, by application and by country, revenue for each segment.

Chapter 8: China by type and by application revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Therapy for Inherited Genetic Disorders revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions

Global Gene Therapy for Inherited Genetic Disorders Market Insights, Forecast to 2029

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy for Inherited Genetic Disorders Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Eye Disorders
1.2.3 Hematological Disorders
1.2.4 Central Nervous System Disorders
1.2.5 Muscular Disorders
1.2.6 Others
1.3 Market by Application
1.3.1 Global Gene Therapy for Inherited Genetic Disorders Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy for Inherited Genetic Disorders Market Perspective (2018-2029)
2.2 Global Gene Therapy for Inherited Genetic Disorders Growth Trends by Region
2.2.1 Gene Therapy for Inherited Genetic Disorders Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gene Therapy for Inherited Genetic Disorders Historic Market Size by Region (2018-2023)
2.2.3 Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Region (2024-2029)
2.3 Gene Therapy for Inherited Genetic Disorders Market Dynamics
2.3.1 Gene Therapy for Inherited Genetic Disorders Industry Trends
2.3.2 Gene Therapy for Inherited Genetic Disorders Market Drivers
2.3.3 Gene Therapy for Inherited Genetic Disorders Market Challenges
2.3.4 Gene Therapy for Inherited Genetic Disorders Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Gene Therapy for Inherited Genetic Disorders by Players
3.1.1 Global Gene Therapy for Inherited Genetic Disorders Revenue by Players (2018-2023)
3.1.2 Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Players (2018-2023)
3.2 Global Gene Therapy for Inherited Genetic Disorders Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Gene Therapy for Inherited Genetic Disorders, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Gene Therapy for Inherited Genetic Disorders Market Concentration Ratio
3.4.1 Global Gene Therapy for Inherited Genetic Disorders Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy for Inherited Genetic Disorders Revenue in 2022
3.5 Global Key Players of Gene Therapy for Inherited Genetic Disorders Head office and Area Served
3.6 Global Key Players of Gene Therapy for Inherited Genetic Disorders, Product and Application
3.7 Global Key Players of Gene Therapy for Inherited Genetic Disorders, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy for Inherited Genetic Disorders Breakdown Data by Type
4.1 Global Gene Therapy for Inherited Genetic Disorders Historic Market Size by Type (2018-2023)
4.2 Global Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Type (2024-2029)
5 Gene Therapy for Inherited Genetic Disorders Breakdown Data by Application
5.1 Global Gene Therapy for Inherited Genetic Disorders Historic Market Size by Application (2018-2023)
5.2 Global Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Gene Therapy for Inherited Genetic Disorders Market Size (2018-2029)
6.2 North America Gene Therapy for Inherited Genetic Disorders Market Size by Type
6.2.1 North America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2018-2023)
6.2.2 North America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2024-2029)
6.2.3 North America Gene Therapy for Inherited Genetic Disorders Market Share by Type (2018-2029)
6.3 North America Gene Therapy for Inherited Genetic Disorders Market Size by Application
6.3.1 North America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2018-2023)
6.3.2 North America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2024-2029)
6.3.3 North America Gene Therapy for Inherited Genetic Disorders Market Share by Application (2018-2029)
6.4 North America Gene Therapy for Inherited Genetic Disorders Market Size by Country
6.4.1 North America Gene Therapy for Inherited Genetic Disorders Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2018-2023)
6.4.3 North America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Gene Therapy for Inherited Genetic Disorders Market Size (2018-2029)
7.2 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type
7.2.1 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type (2018-2023)
7.2.2 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type (2024-2029)
7.2.3 Europe Gene Therapy for Inherited Genetic Disorders Market Share by Type (2018-2029)
7.3 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application
7.3.1 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application (2018-2023)
7.3.2 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application (2024-2029)
7.3.3 Europe Gene Therapy for Inherited Genetic Disorders Market Share by Application (2018-2029)
7.4 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country
7.4.1 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country (2018-2023)
7.4.3 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Gene Therapy for Inherited Genetic Disorders Market Size (2018-2029)
8.2 China Gene Therapy for Inherited Genetic Disorders Market Size by Type
8.2.1 China Gene Therapy for Inherited Genetic Disorders Market Size by Type (2018-2023)
8.2.2 China Gene Therapy for Inherited Genetic Disorders Market Size by Type (2024-2029)
8.2.3 China Gene Therapy for Inherited Genetic Disorders Market Share by Type (2018-2029)
8.3 China Gene Therapy for Inherited Genetic Disorders Market Size by Application
8.3.1 China Gene Therapy for Inherited Genetic Disorders Market Size by Application (2018-2023)
8.3.2 China Gene Therapy for Inherited Genetic Disorders Market Size by Application (2024-2029)
8.3.3 China Gene Therapy for Inherited Genetic Disorders Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Gene Therapy for Inherited Genetic Disorders Market Size (2018-2029)
9.2 Asia Gene Therapy for Inherited Genetic Disorders Market Size by Type
9.2.1 Asia Gene Therapy for Inherited Genetic Disorders Market Size by Type (2018-2023)
9.2.2 Asia Gene Therapy for Inherited Genetic Disorders Market Size by Type (2024-2029)
9.2.3 Asia Gene Therapy for Inherited Genetic Disorders Market Share by Type (2018-2029)
9.3 Asia Gene Therapy for Inherited Genetic Disorders Market Size by Application
9.3.1 Asia Gene Therapy for Inherited Genetic Disorders Market Size by Application (2018-2023)
9.3.2 Asia Gene Therapy for Inherited Genetic Disorders Market Size by Application (2024-2029)
9.3.3 Asia Gene Therapy for Inherited Genetic Disorders Market Share by Application (2018-2029)
9.4 Asia Gene Therapy for Inherited Genetic Disorders Market Size by Region
9.4.1 Asia Gene Therapy for Inherited Genetic Disorders Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Gene Therapy for Inherited Genetic Disorders Market Size by Region (2018-2023)
9.4.3 Asia Gene Therapy for Inherited Genetic Disorders Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Type
10.2.1 Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Application
10.3.1 Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Country
10.4.1 Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 BioMarin Pharmaceutical Inc.
11.1.1 BioMarin Pharmaceutical Inc. Company Details
11.1.2 BioMarin Pharmaceutical Inc. Business Overview
11.1.3 BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Introduction
11.1.4 BioMarin Pharmaceutical Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2018-2023)
11.1.5 BioMarin Pharmaceutical Inc. Recent Developments
11.2 bluebird bio Inc.
11.2.1 bluebird bio Inc. Company Details
11.2.2 bluebird bio Inc. Business Overview
11.2.3 bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Introduction
11.2.4 bluebird bio Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2018-2023)
11.2.5 bluebird bio Inc. Recent Developments
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Gene Therapy for Inherited Genetic Disorders Introduction
11.3.4 Novartis AG Revenue in Gene Therapy for Inherited Genetic Disorders Business (2018-2023)
11.3.5 Novartis AG Recent Developments
11.4 Orchard Therapeutics Plc
11.4.1 Orchard Therapeutics Plc Company Details
11.4.2 Orchard Therapeutics Plc Business Overview
11.4.3 Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Introduction
11.4.4 Orchard Therapeutics Plc Revenue in Gene Therapy for Inherited Genetic Disorders Business (2018-2023)
11.4.5 Orchard Therapeutics Plc Recent Developments
11.5 Spark Therapeutics Inc.
11.5.1 Spark Therapeutics Inc. Company Details
11.5.2 Spark Therapeutics Inc. Business Overview
11.5.3 Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Introduction
11.5.4 Spark Therapeutics Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2018-2023)
11.5.5 Spark Therapeutics Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Gene Therapy for Inherited Genetic Disorders Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Eye Disorders
Table 3. Key Players of Hematological Disorders
Table 4. Key Players of Central Nervous System Disorders
Table 5. Key Players of Muscular Disorders
Table 6. Key Players of Others
Table 7. Global Gene Therapy for Inherited Genetic Disorders Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 8. Global Gene Therapy for Inherited Genetic Disorders Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Gene Therapy for Inherited Genetic Disorders Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Gene Therapy for Inherited Genetic Disorders Market Share by Region (2018-2023)
Table 11. Global Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Gene Therapy for Inherited Genetic Disorders Market Share by Region (2024-2029)
Table 13. Gene Therapy for Inherited Genetic Disorders Market Trends
Table 14. Gene Therapy for Inherited Genetic Disorders Market Drivers
Table 15. Gene Therapy for Inherited Genetic Disorders Market Challenges
Table 16. Gene Therapy for Inherited Genetic Disorders Market Restraints
Table 17. Global Gene Therapy for Inherited Genetic Disorders Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Gene Therapy for Inherited Genetic Disorders Revenue Share by Players (2018-2023)
Table 19. Global Top Gene Therapy for Inherited Genetic Disorders by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy for Inherited Genetic Disorders as of 2022)
Table 20. Global Gene Therapy for Inherited Genetic Disorders Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Gene Therapy for Inherited Genetic Disorders Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Gene Therapy for Inherited Genetic Disorders, Headquarters and Area Served
Table 23. Global Key Players of Gene Therapy for Inherited Genetic Disorders, Product and Application
Table 24. Global Key Players of Gene Therapy for Inherited Genetic Disorders, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Gene Therapy for Inherited Genetic Disorders Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Type (2018-2023)
Table 28. Global Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Type (2024-2029)
Table 30. Global Gene Therapy for Inherited Genetic Disorders Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Gene Therapy for Inherited Genetic Disorders Revenue Share by Application (2018-2023)
Table 32. Global Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Gene Therapy for Inherited Genetic Disorders Revenue Share by Application (2024-2029)
Table 34. North America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2024-2029) & (US$ Million)
Table 36. North America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2024-2029) & (US$ Million)
Table 38. North America Gene Therapy for Inherited Genetic Disorders Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. North America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2024-2029) & (US$ Million)
Table 41. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type (2024-2029) & (US$ Million)
Table 43. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application (2024-2029) & (US$ Million)
Table 45. Europe Gene Therapy for Inherited Genetic Disorders Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country (2024-2029) & (US$ Million)
Table 48. China Gene Therapy for Inherited Genetic Disorders Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Gene Therapy for Inherited Genetic Disorders Market Size by Type (2024-2029) & (US$ Million)
Table 50. China Gene Therapy for Inherited Genetic Disorders Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Gene Therapy for Inherited Genetic Disorders Market Size by Application (2024-2029) & (US$ Million)
Table 52. Asia Gene Therapy for Inherited Genetic Disorders Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Gene Therapy for Inherited Genetic Disorders Market Size by Type (2024-2029) & (US$ Million)
Table 54. Asia Gene Therapy for Inherited Genetic Disorders Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Gene Therapy for Inherited Genetic Disorders Market Size by Application (2024-2029) & (US$ Million)
Table 56. Asia Gene Therapy for Inherited Genetic Disorders Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 57. Asia Gene Therapy for Inherited Genetic Disorders Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Gene Therapy for Inherited Genetic Disorders Market Size by Region (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 64. Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2024-2029) & (US$ Million)
Table 66. BioMarin Pharmaceutical Inc. Company Details
Table 67. BioMarin Pharmaceutical Inc. Business Overview
Table 68. BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Product
Table 69. BioMarin Pharmaceutical Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2018-2023) & (US$ Million)
Table 70. BioMarin Pharmaceutical Inc. Recent Developments
Table 71. bluebird bio Inc. Company Details
Table 72. bluebird bio Inc. Business Overview
Table 73. bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Product
Table 74. bluebird bio Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2018-2023) & (US$ Million)
Table 75. bluebird bio Inc. Recent Developments
Table 76. Novartis AG Company Details
Table 77. Novartis AG Business Overview
Table 78. Novartis AG Gene Therapy for Inherited Genetic Disorders Product
Table 79. Novartis AG Revenue in Gene Therapy for Inherited Genetic Disorders Business (2018-2023) & (US$ Million)
Table 80. Novartis AG Recent Developments
Table 81. Orchard Therapeutics Plc Company Details
Table 82. Orchard Therapeutics Plc Business Overview
Table 83. Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Product
Table 84. Orchard Therapeutics Plc Revenue in Gene Therapy for Inherited Genetic Disorders Business (2018-2023) & (US$ Million)
Table 85. Orchard Therapeutics Plc Recent Developments
Table 86. Spark Therapeutics Inc. Company Details
Table 87. Spark Therapeutics Inc. Business Overview
Table 88. Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Product
Table 89. Spark Therapeutics Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2018-2023) & (US$ Million)
Table 90. Spark Therapeutics Inc. Recent Developments
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapy for Inherited Genetic Disorders Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Gene Therapy for Inherited Genetic Disorders Market Share by Type: 2022 VS 2029
Figure 3. Eye Disorders Features
Figure 4. Hematological Disorders Features
Figure 5. Central Nervous System Disorders Features
Figure 6. Muscular Disorders Features
Figure 7. Others Features
Figure 8. Global Gene Therapy for Inherited Genetic Disorders Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Gene Therapy for Inherited Genetic Disorders Market Share by Application: 2022 VS 2029
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Research Institute Case Studies
Figure 13. Others Case Studies
Figure 14. Gene Therapy for Inherited Genetic Disorders Report Years Considered
Figure 15. Global Gene Therapy for Inherited Genetic Disorders Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Gene Therapy for Inherited Genetic Disorders Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Gene Therapy for Inherited Genetic Disorders Market Share by Region: 2022 VS 2029
Figure 18. Global Gene Therapy for Inherited Genetic Disorders Market Share by Players in 2022
Figure 19. Global Top Gene Therapy for Inherited Genetic Disorders Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy for Inherited Genetic Disorders as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Gene Therapy for Inherited Genetic Disorders Revenue in 2022
Figure 21. North America Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Gene Therapy for Inherited Genetic Disorders Market Share by Type (2018-2029)
Figure 23. North America Gene Therapy for Inherited Genetic Disorders Market Share by Application (2018-2029)
Figure 24. North America Gene Therapy for Inherited Genetic Disorders Market Share by Country (2018-2029)
Figure 25. United States Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Gene Therapy for Inherited Genetic Disorders Market Size YoY (2018-2029) & (US$ Million)
Figure 28. Europe Gene Therapy for Inherited Genetic Disorders Market Share by Type (2018-2029)
Figure 29. Europe Gene Therapy for Inherited Genetic Disorders Market Share by Application (2018-2029)
Figure 30. Europe Gene Therapy for Inherited Genetic Disorders Market Share by Country (2018-2029)
Figure 31. Germany Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. France Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. U.K. Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Italy Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Russia Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Nordic Countries Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. China Gene Therapy for Inherited Genetic Disorders Market Size YoY (2018-2029) & (US$ Million)
Figure 38. China Gene Therapy for Inherited Genetic Disorders Market Share by Type (2018-2029)
Figure 39. China Gene Therapy for Inherited Genetic Disorders Market Share by Application (2018-2029)
Figure 40. Asia Gene Therapy for Inherited Genetic Disorders Market Size YoY (2018-2029) & (US$ Million)
Figure 41. Asia Gene Therapy for Inherited Genetic Disorders Market Share by Type (2018-2029)
Figure 42. Asia Gene Therapy for Inherited Genetic Disorders Market Share by Application (2018-2029)
Figure 43. Asia Gene Therapy for Inherited Genetic Disorders Market Share by Region (2018-2029)
Figure 44. Japan Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. South Korea Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. China Taiwan Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Southeast Asia Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. India Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Australia Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Size YoY (2018-2029) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Share by Type (2018-2029)
Figure 52. Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Share by Application (2018-2029)
Figure 53. Middle East, Africa, and Latin America Gene Therapy for Inherited Genetic Disorders Market Share by Country (2018-2029)
Figure 54. Brazil Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Mexico Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Turkey Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Israel Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. GCC Countries Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. BioMarin Pharmaceutical Inc. Revenue Growth Rate in Gene Therapy for Inherited Genetic Disorders Business (2018-2023)
Figure 61. bluebird bio Inc. Revenue Growth Rate in Gene Therapy for Inherited Genetic Disorders Business (2018-2023)
Figure 62. Novartis AG Revenue Growth Rate in Gene Therapy for Inherited Genetic Disorders Business (2018-2023)
Figure 63. Orchard Therapeutics Plc Revenue Growth Rate in Gene Therapy for Inherited Genetic Disorders Business (2018-2023)
Figure 64. Spark Therapeutics Inc. Revenue Growth Rate in Gene Therapy for Inherited Genetic Disorders Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs